178 related articles for article (PubMed ID: 34298356)
1. Can the booster interval for the tick-borne encephalitis (TBE) vaccine 'FSME-IMMUN' be prolonged? - A systematic review.
Steffen R; Erber W; Schmitt HJ
Ticks Tick Borne Dis; 2021 Sep; 12(5):101779. PubMed ID: 34298356
[TBL] [Abstract][Full Text] [Related]
2. Seropersistence of TBE virus antibodies 10 years after first booster vaccination and response to a second booster vaccination with FSME-IMMUN 0.5mL in adults.
Konior R; Brzostek J; Poellabauer EM; Jiang Q; Harper L; Erber W
Vaccine; 2017 Jun; 35(28):3607-3613. PubMed ID: 28545923
[TBL] [Abstract][Full Text] [Related]
3. Seropersistence of tick-borne encephalitis antibodies, safety and booster response to FSME-IMMUN 0.5 ml in adults aged 18-67 years.
Loew-Baselli A; Poellabauer EM; Pavlova BG; Fritsch S; Koska M; Bobrovsky R; Konior R; Ehrlich HJ
Hum Vaccin; 2009 Aug; 5(8):551-6. PubMed ID: 19430202
[TBL] [Abstract][Full Text] [Related]
4. Five year follow-up after primary vaccination against tick-borne encephalitis in children.
Wittermann C; Izu A; Petri E; Gniel D; Fragapane E
Vaccine; 2015 Apr; 33(15):1824-9. PubMed ID: 25728316
[TBL] [Abstract][Full Text] [Related]
5. Seropersistence and booster response following vaccination with FSME-IMMUN in children, adolescents, and young adults.
Poellabauer E; Angermayr R; Behre U; Zhang P; Harper L; Schmitt HJ; Erber W
Vaccine; 2019 May; 37(24):3241-3250. PubMed ID: 30928173
[TBL] [Abstract][Full Text] [Related]
6. Antibody response following administration of two paediatric tick-borne encephalitis vaccines using two different vaccination schedules.
Wittermann C; Schöndorf I; Gniel D
Vaccine; 2009 Mar; 27(10):1661-6. PubMed ID: 18940221
[TBL] [Abstract][Full Text] [Related]
7. Tick-borne encephalitis (TBE) vaccine 'FSME-IMMUN' boosters - response to the letter by Bernard Hoet and Victoria Jenkins.
Steffen R
Ticks Tick Borne Dis; 2022 Mar; 13(2):101889. PubMed ID: 34953336
[No Abstract] [Full Text] [Related]
8. Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis.
Domnich A; Panatto D; Arbuzova EK; Signori A; Avio U; Gasparini R; Amicizia D
Hum Vaccin Immunother; 2014; 10(10):2819-33. PubMed ID: 25483679
[TBL] [Abstract][Full Text] [Related]
9. Irregular tick-borne encephalitis vaccination schedules: the effect of a single catch-up vaccination with FSME-IMMUN. A prospective non-interventional study.
Schosser R; Reichert A; Mansmann U; Unger B; Heininger U; Kaiser R
Vaccine; 2014 Apr; 32(20):2375-81. PubMed ID: 24613521
[TBL] [Abstract][Full Text] [Related]
10. Letter to the editor for: Can the booster interval for the tick-borne encephalitis (TBE) vaccine 'FSME-IMMUN' be prolonged? - A systematic review.
Hoet B; Jenkins V
Ticks Tick Borne Dis; 2022 Jul; 13(4):101953. PubMed ID: 35405361
[No Abstract] [Full Text] [Related]
11. Serological response to tick-borne encephalitis (TBE) vaccination in the elderly--results from an observational study.
Jílková E; Vejvalková P; Stiborová I; Skorkovský J; Král V
Expert Opin Biol Ther; 2009 Jul; 9(7):797-803. PubMed ID: 19527104
[TBL] [Abstract][Full Text] [Related]
12. Antibody persistence after two vaccinations with either FSME-IMMUN® Junior or ENCEPUR® Children followed by third vaccination with FSME-IMMUN® Junior.
Prymula R; Pöllabauer EM; Pavlova BG; Löw-Baselli A; Fritsch S; Angermayr R; Geisberger A; Barrett PN; Ehrlich HJ
Hum Vaccin Immunother; 2012 Jun; 8(6):736-42. PubMed ID: 22699436
[TBL] [Abstract][Full Text] [Related]
13. Prevention of tick-borne encephalitis by FSME-IMMUN vaccines: review of a clinical development programme.
Loew-Baselli A; Poellabauer EM; Pavlova BG; Fritsch S; Firth C; Petermann R; Barrett PN; Ehrlich HJ
Vaccine; 2011 Oct; 29(43):7307-19. PubMed ID: 21843576
[TBL] [Abstract][Full Text] [Related]
14. Second five-year follow-up after a booster vaccination against tick-borne encephalitis following different primary vaccination schedules demonstrates at least 10 years antibody persistence.
Beran J; Lattanzi M; Xie F; Moraschini L; Galgani I
Vaccine; 2019 Jul; 37(32):4623-4629. PubMed ID: 29397225
[TBL] [Abstract][Full Text] [Related]
15. Three-dose versus four-dose primary schedules for tick-borne encephalitis (TBE) vaccine FSME-immun for those aged 50 years or older: A single-centre, open-label, randomized controlled trial.
Kantele A; Rombo L; Vene S; Kundi M; Lindquist L; Erra EO
Vaccine; 2022 Feb; 40(9):1299-1305. PubMed ID: 35101266
[TBL] [Abstract][Full Text] [Related]
16. Evidence for a 10-year TBE vaccine booster interval: an evaluation of current data.
Schelling J; Einmahl S; Torgler R; Larsen CS
Expert Rev Vaccines; 2024; 23(1):226-236. PubMed ID: 38288983
[TBL] [Abstract][Full Text] [Related]
17. Vaccination against tick-borne encephalitis--distant evaluation.
Bobrowska E; Grzeszczuk A; Prokopowicz D
Rocz Akad Med Bialymst; 1996; 41(1):44-50. PubMed ID: 8673804
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of TBE vaccination in southern Germany and Latvia.
Erber W; Khan F; Zavadska D; Freimane Z; Dobler G; Böhmer MM; Jodar L; Schmitt HJ
Vaccine; 2022 Jan; 40(5):819-825. PubMed ID: 34952753
[TBL] [Abstract][Full Text] [Related]
19. Long-term immunity after vaccination against tick-borne encephalitis with Encepur using the rapid vaccination schedule.
Beran J; Douda P; Gniel D; Zent O
Int J Med Microbiol; 2004 Apr; 293 Suppl 37():130-3. PubMed ID: 15146994
[TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN: results of two large phase 3 clinical studies.
Loew-Baselli A; Konior R; Pavlova BG; Fritsch S; Poellabauer E; Maritsch F; Harmacek P; Krammer M; Barrett PN; Ehrlich HJ;
Vaccine; 2006 Jun; 24(24):5256-63. PubMed ID: 16624457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
